PAPatricia Verónica Aulestia-Viera

Patricia Verónica Aulestia-Viera

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Patricia Verónica Aulestia-Viera has a total of 57 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Malignant tumors affecting the head and neck region in ancient times: Comprehensive study of the CRAB Database

    by Patricia Verónica Aulestia-Viera, Carla Isabelly Rodrigues-Fernandes, Thaís Bianca Brandão, André Caroli Rocha, Pablo Agustin Vargas, Marcio Ajudarte Lopes, Newell Walter Johnson, Luiz Paulo Kowalski, Ana Carolina Prado Ribeiro, Alan Roger Santos-Silva

    In the modern world, cancer is a growing cause of mortality, but archeological studies have shown that it is not exclusive to modern populations. The aim of this study is to examine the epidemiologic, social, and clinicopathologic features of head and neck cancers in ancient populations. To do this, we extracted all records that described malignant lesions in the head and neck region available in the Cancer Research in Ancient Bodies Database (CRAB). The estimated age, sex, physical condition of the remains (skeletonized, mummified), anatomic location of tumors, geographic location, chronology, tumor type, and methods of tumor diagnosis were collected. One hundred and sixty-seven cases were found, mostly originating from Europe (51.5%). Most records were of adults between 35 and 49 years of age (37.7%). The most involved site was the skullcap (60.4%), and the most common malignancies were metastases to the bone (65.3%) and multiple myeloma (17.4%). No primary soft tissue malignancies were registered. The results of our study indicate that head and neck cancers were present in ancient civilizations, at least since 500,000 BCE. The available data can help to improve the current understanding of the global distribution of head and neck cancer and its multidimensional impacts on populations in the contemporary world.


  • POSITIVE OUTCOMES OF DENOSUMAB IN THE TREATMENT OF CENTRAL GIANT CELL LESIONS: CASE SERIES

    by Patricia Verónica Aulestia-Viera, Alan Roger Santos-Silva, Regina Matsunaga Martin, Cristiane Melo Da Silva Santos, Gustavo Grothe Machado, André Caroli Rocha


  • Open Access

    Caso raro de anquilose da ATM oriunda de radioterapia: revisão sistemática de diferentes etiologias

    by Bruno da Silva Mesquita, Patrícia Verónica Aulestia Viera, Ana Cláudia Amorim Gomes Dourado, Emanuel Savio de Souza Andrade, Francisco Orlando Giraldi Neto, Ulisses Estevam Alves Neto, Douglas da Cunha Vieira

    A anquilose da articulação temporomandibular ainda é um assunto em evidência na literatura sendo foco de várias divergências de opiniões principalmente no que se refere à etiologia e tratamento. Com base nisso, esse estudo tem como objetivo apresentar uma revisão sistemática sobre o tema ilustrando-o através de um relato caso clínico de anquilose bilateral de ATM que ocorreu como sequela de radioterapia utilizada no tratamento de um linfoepitelioma de nasofaringe. No caso relatado a anquilose bilateral da ATM se deu de forma progressiva por 20 anos. Essa condição foi tratada com remoção cirúrgica da anquilose e instalação de prótese customizada bilateral. Na revisão sistemática da literatura a etiologia mais referida foi o trauma, representando a grande maioria com 1185 casos, seguido de 110 casos de infecção, 1 de hiperplasia do processo coronoide da mandíbula, 102 idiopáticas, 17 congênitas, 10 problemas sistêmicos (como osteoartrite e espondilite) e 18 por cirurgia prévia. A radioterapia como fator etiológico para as anquiloses de ATM deve ser levada em conta sendo assim necessário a realização de estudos que sugiram protocolos de prevenção específicos.

  • Manejo odontológico del paciente con anemia falciforme: revisión integrativa

    by Patricia Verónica Aulestia-Viera, Isadora Dourado Cardoso Alves, Gabriela Moura Chicrala, Paulo Sergio Da Silva Santos, Luiz Alberto Valente Soares Junior

    La anemia falciforme (AF) es un trastorno genético autosómico recesivo que afecta la hemoglobina y los glóbulos rojos adquieren una forma de hoz. Este evento provoca episodios de vaso-oclusión y hemólisis y, en consecuencia, una amplia gama de manifestaciones clínicas. Objetivo: realizar una revisión bibliográfica integrativa sobre el cuidado dental para pacientes con anemia falciforme. Materiales y Métodos: Se realizó una búsqueda en las bases de datos de PubMed y SciELO, utilizando como estrategia una asociación de términos relacionados ("Anemia de Células Falciformes" y " Atención Odontológica"). Resultados: Se incluyeron los artículos publicados a partir de 1990 y se excluyeron revisiones de literatura, lo que resultó en dieciocho artículos para análisis. La evidencia científica demostró que la atención odontológica preventiva es esencial para los pacientes con anemia falciforme, ya que puede reducir el número de ingresos hospitalarios. Las medidas previas, durante y posteriores al tratamiento pueden incluir profilaxis antibiótica, uso de sedación, buen control de los niveles de oxígeno, hidratación del paciente y mantenimiento de una perfusión tisular adecuada. Sin embargo, persisten algunas dudas, sobre la seguridad del uso de anestésicos locales con vasoconstrictores y la oseointegración de implantes dentales. Conclusión: El conocimiento de la enfermedad es esencial para el tratamiento dental de pacientes con anemia falciforme; durante la atención, se debe tener en cuenta ciertos cuidados para reducir los factores que promueven crisis agudas como acidosis, hipotensión, hipoxia, infección, vasoconstricción y estrés.


  • Open Access

    Denosumab-related osteonecrosis of the jaw

    by Patricia Verónica Aulestia-Viera, Alan Roger Santos-Silva, Gustavo Grothe Machado, André Caroli Rocha

    Denosumab (DNB) is a human monoclonal antibody, successfully used for the treatment of osteoporosis and some types of malignant neoplasms. Nevertheless, medication-related osteonecrosis of the jaw (MRONJ) is one of its possible side effects. The aim of this study was to summarize the etiology, characteristics, treatment options and prognosis of MRONJ caused by DNB through a systematic review of reported cases. A search was conducted on the Pubmed, Scopus, and Scielo databases, including case reports and case series articles, published until October 2019 about the effect of this drug in the oral and maxillofacial area. Forty-three articles were included, totaling 145 reported cases of MRONJ cases related to DNB. The mean age of the patients was 68.3 years, and the mandible was more affected than the maxilla. The most common triggering factor was dental extractions (60%), although it could happen spontaneously. The prescription of antibiotics and oral rinses, followed by removal of necrotic bone were performed in most articles (106 cases, 73%). In 68.9% of these surgical cases, a total remission of MRONJ was seen. Onset of MRONJ led to discontinuation of denosumab DNB in 42% of the cases. Adjuvant therapies have also been reported to increase treatment success. The increased use of DNB in the treatment of cancer, osteoporosis and other bone conditions highlights the importance of knowing the characteristics DNB-related MRONJ, the possibility of prevention and its treatment options. This review showed that this condition can be controlled with antibiotic therapy, mouthwashes and removal of devitalized bone. Apparently, the use of teriparatide or leucocyte- and platelet-rich fibrin could also contribute to its resolution. However, clinical studies have yet to be performed to support the findings of this systematic review of case reports.

  • Juvenile ossifying fibroma of the maxilla: a case report

    by P. Aulestia-Viera, G. Paiva, M. Lopes, P. Vargas, G. Machado, M. Bertotti, L. Mariotto, A. Rocha

  • Oxytetracycline-loaded polymeric nanofibers for the treatment of dry socket: an in vivo evaluation

    by P. Aulestia-Viera, L. Nogueira, C. Barros Neto, R. Rocha, M. Cortés, L. Corrêa, M. dos Santos, M. Borsatti

  • Guaiacol/β-cyclodextrin for rapid healing of dry socket: antibacterial activity, cytotoxicity, and bone repair—an animal study

    by Patricia Verónica Aulestia-Viera, Sávio Morato Lacerda Gontijo, Alinne Damásia Martins Gomes, Rubén Dario Sinisterra, Rodney Garcia Rocha, Maria Esperanza Cortés, Marinilce Fagundes dos Santos, Maria Aparecida Borsatti

    Dry socket (DS) is one the most common and symptomatic post-extraction complications; however, no consensus on its treatment has been reached. This study aimed to develop a novel dressing material for DS containing the phenolic agent guaiacol and evaluate its biological properties.


  • Open Access

    Late hyaluronidase injection in local anesthesia: Morphofunctional evaluation in rat sciatic nerve block

    by Maria Aparecida Borsatti, Anna Carolina Ratto Tempestini-Horliana, Marcelo Lazzaron Lamers, Maurício Yonamine, Patricia Verónica Aulestia-Viera, Marinilce Fagundes Dos Santos

    Introduction: Despite the enhancing effects of hyaluronidase (HYAL) over duration of anesthesia, this enzyme could cause adverse effects when injected concomitantly with local anesthetics in dental blocks. Objective: This study aimed to assess the tissue alterations caused by a local anesthetic protocol consisting of a late HYAL injection and confirm its functional effectiveness. Materials and Methods: The protocol efficacy was proved by evaluating sensory and motor functions in rats. The sciatic nerve was blocked with 2% lidocaine (LID) with epinephrine (n = 25). Thirty minutes later, 75 TRU/ml HYAL was injected into the same site (experimental group, LID/HYAL). One week later, this protocol was repeated in the contralateral hindlimb, injecting only HYAL's vehicle (control group, LID/vehicle [LID/V]). To observe the integrity of the local tissues, histological specimens were obtained 1, 24, 48, and 72 h after treatment with LID/HYAL or LID/V (n = 16 each) and stained with hematoxylin/eosin and picrosirius red. Results: Local inflammation was similar in both groups. The integrity of the nerve fibers was preserved, in spite of some inflammation-associated injuries in the surrounding tissues. The reversible tissue disorganization caused by HYAL, probably facilitated the diffusion of the residual anesthetic to the nerve, resulting in a prolonged anesthetic effect (P < 0.05). Conclusions: No irreversible morphological alterations are caused by the administration of HYAL prior the end of the LID-induced block. Moreover, this protocol prolongs LID's anesthetic effect.


  • The effect of adjusting the pH of local anaesthetics in dentistry: a systematic review and meta‐analysis

    by P. V. Aulestia‐Viera, M. M. Braga, M. A. Borsatti

    The acidic nature of commercial local anaesthetics (LAs) can cause pain during infiltration and delay the onset of anaesthesia. It is suggested that adjusting the pH of anaesthetic agents could minimize these effects. This systematic review aimed to evaluate the efficacy of buffered LAs in reducing infiltration pain and onset time during dental procedures. MEDLINE, Embase, Scopus and Scielo databases were searched up to April 2017. Randomized controlled trials comparing buffered and unbuffered LAs for intraoral injections were included. Risk of bias was assessed using the Cochrane Collaboration tool. Data upon injection pain and onset time were pooled in a random‐effects model. Subgroup analyses compared normal and inflamed tissues, and terminal infiltrations and inferior alveolar nerve (IAN) blocks. Meta‐regressions were performed to explain heterogeneity. Fourteen articles were included in this review. Lidocaine with epinephrine was the most used anaesthetic combination. Nonlidocaine studies (n = 2) were not pooled in the meta‐analysis. Buffered lidocaine did not result in less pain during intraoral injections: mean difference −6.4 (95% CI −12.81 to 0.01) units in a 0–100 scale. Alkalinized lidocaine did not reduce the onset time in normal tissues when terminal infiltration techniques were used, but resulted in a more rapid onset for IAN blocks (−1.26 min) and in inflamed tissues (−1.37 min); however, this change may not be clinically relevant, considering the time required to prepare the buffered agent. Studies performed using other anaesthetic salts did not show robust and clinically significant results in favour of alkalinization.